XML 47 R28.htm IDEA: XBRL DOCUMENT
v3.19.3

Revenue Recognition - Disaggregated Sales Analysis (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | $ 3,587 | $ 3,242 | $ 10,753 | $ 9,805
United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 2,644 | 2,381 | 7,918 | 7,080
International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 943 | 861 | 2,835 | 2,725
Orthopaedics |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,262 | 1,171 | 3,785 | 3,615
Orthopaedics | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 872 | 798 | 2,596 | 2,433
Orthopaedics | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 390 | 373 | 1,189 | 1,182
Orthopaedics | Knees |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 426 | 395 | 1,305 | 1,236
Orthopaedics | Knees | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 318 | 291 | 962 | 896
Orthopaedics | Knees | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 108 | 104 | 343 | 340
Orthopaedics | Hips |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 332 | 316 | 1,011 | 983
Orthopaedics | Hips | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 211 | 198 | 643 | 610
Orthopaedics | Hips | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 121 | 118 | 368 | 373
Orthopaedics | Trauma and Extremities |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 407 | 376 | 1,197 | 1,152
Orthopaedics | Trauma and Extremities | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 262 | 242 | 768 | 729
Orthopaedics | Trauma and Extremities | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 145 | 134 | 429 | 423
Orthopaedics | Other |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 97 | 84 | 272 | 244
Orthopaedics | Other | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 81 | 67 | 223 | 198
Orthopaedics | Other | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 16 | 17 | 49 | 46
MedSurg |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,576 | 1,443 | 4,737 | 4,325
MedSurg | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,263 | 1,157 | 3,802 | 3,403
MedSurg | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 313 | 286 | 935 | 922
MedSurg | Instruments |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 476 | 442 | 1,474 | 1,292
MedSurg | Instruments | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 373 | 352 | 1,168 | 1,007
MedSurg | Instruments | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 103 | 90 | 306 | 285
MedSurg | Endoscopy |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 474 | 443 | 1,424 | 1,335
MedSurg | Endoscopy | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 377 | 346 | 1,136 | 1,049
MedSurg | Endoscopy | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 97 | 97 | 288 | 286
MedSurg | Medical |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 554 | 492 | 1,627 | 1,508
MedSurg | Medical | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 442 | 393 | 1,288 | 1,158
MedSurg | Medical | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 112 | 99 | 339 | 350
MedSurg | Sustainability |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 72 | 66 | 212 | 190
MedSurg | Sustainability | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 71 | 66 | 210 | 189
MedSurg | Sustainability | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1 | 0 | 2 | 1
Neurotechnology and Spine |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 749 | 628 | 2,231 | 1,865
Neurotechnology and Spine | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 509 | 426 | 1,520 | 1,244
Neurotechnology and Spine | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 240 | 202 | 711 | 621
Neurotechnology and Spine | Neurotechnology |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 488 | 435 | 1,436 | 1,282
Neurotechnology and Spine | Neurotechnology | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 314 | 284 | 922 | 820
Neurotechnology and Spine | Neurotechnology | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 174 | 150 | 514 | 462
Neurotechnology and Spine | Spine |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 261 | 193 | 795 | 583
Neurotechnology and Spine | Spine | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 195 | 142 | 598 | 424
Neurotechnology and Spine | Spine | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | $ 66 | $ 52 | $ 197 | $ 159

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_KneesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_HipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_TraumaandExtremitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_OtherOrthopaedicsDomain
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=syk_MedsurgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_InstrumentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_EndoscopyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_MedicalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_SustainabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=syk_NeurotechnologyAndSpineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_NeurotechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_SpineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |